ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
5 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wilba32
|
8.9K |
3.3M |
7 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wilba32
|
8.9K |
3.3M |
8 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
12 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
0 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
12 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
32K |
10 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
87
|
32K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
32K |
6 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
87
|
32K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.4K |
2.7M |
11 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
32K |
3 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
87
|
32K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
32K |
7 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
87
|
32K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
32K |
7 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
87
|
32K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
6 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
1.0K
|
418K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
32K |
10 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
87
|
32K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
5 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.0K
|
418K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
10 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.0K
|
418K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
32K |
16 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
87
|
32K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.9K |
2.9M |
15 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Wilba32
|
244 |
89K |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
244
|
89K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Wilba32
|
244 |
89K |
10 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
244
|
89K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Wilba32
|
244 |
89K |
6 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
244
|
89K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Wilba32
|
244 |
89K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
244
|
89K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Wilba32
|
244 |
89K |
4 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
244
|
89K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
2 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
1.0K
|
418K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
8 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wilba32
|
8.9K |
3.3M |
10 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Wilba32
|
244 |
89K |
13 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
244
|
89K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
5 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wilba32
|
8.9K |
3.3M |
21 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
1 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
26 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Wilba32
|
244 |
89K |
13 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
244
|
89K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Wilba32
|
244 |
89K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
244
|
89K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
2 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
1.0K
|
418K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
Wilba32
|
244 |
89K |
15 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
244
|
89K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
8 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
1.0K
|
418K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
5 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
1.0K
|
418K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Wilba32
|
671 |
236K |
8 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
671
|
236K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
4 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
418K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
418K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
5 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
418K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
16 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
418K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.9K |
2.9M |
20 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.9K |
2.9M |
9 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
4 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
418K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.9K |
2.9M |
7 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.9K |
2.9M |
20 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
9.9K
|
2.9M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
28 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
17K
|
6.7M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
17 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
17K
|
6.7M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
418K |
14 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
1.0K
|
418K
|
14
|
|